Skip to main content

Advertisement

Log in

Outcome from a Community-based Smoking Cessation Program for Persons with Serious Mental Illness

  • Original Paper
  • Published:
Community Mental Health Journal Aims and scope Submit manuscript

Abstract

Six and 12-month outcomes are reported on 79 mentally ill persons attending either a 4- or 8-session community-based smoking cessation group. Quit rates at post, 3-, 6-, and 12-month follow-ups were 16, 19, 16, and 19%, respectively, with no significant effect of program length. These success rates are comparable to outcomes reported following group-based treatment with mentally healthy smokers. The majority of quitters used nicotine replacement therapy. Psychotropic medication dosages did not vary over time in quitters or non-quitters. No reductions in smoking were observed among non-quitters. Quitting smoking had no untoward effects on symptoms of mental illness or general functioning.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Abrams, D. B., Niaura, R., Brown, R. A., Emmons, K. M., Goldstein, M. G., & Monti, P. M. (2003). The Tobacco Dependence Treatment Handbook. New York: Guilford Press.

    Google Scholar 

  • Addington, J., el-Guebaly, N., Campbell, W., Hodgins, D., & Addington, D. (1998). Smoking cessation treatment for patients with schizophrenia. American Journal of Psychiatry, 155, 974–976.

    CAS  PubMed  Google Scholar 

  • American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.

    Google Scholar 

  • Brown, S. (1997). Excess mortality of schizophrenia: A meta-analysis. British Journal of Psychiatry, 171, 502–508.

    CAS  PubMed  Google Scholar 

  • de Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. [References]. Schizophrenia Research, 76, 135–157.

    Article  PubMed  Google Scholar 

  • Derogatis, L. R., & Melisaratos, N. (1983). The brief symptom inventory: An introductory report. Psychological Medicine, 130, 595–605.

    Article  Google Scholar 

  • Dubovsky, S. (2005). Benzodiazepine receptor agonists and antagonists. In B.J. Sadock, & V. A. Sadock (Eds.), Comprehensive Textbook of Psychiatry, (Vol. 2, 8th ed., pp. 2789). Philadelphia: Lippincott Williams & Wilkins.

    Google Scholar 

  • Dursun, S., & Kutcher, S. (1999). Smoking, nicotine and psychiatric disorders: Evidence for therapeutic role, controversies and implications for future research. Medical Hypotheses, 52, 101–109.

    Article  CAS  PubMed  Google Scholar 

  • el-Guebaly, N., Cathcart, J., Currie, S., Brown, D., & Gloster, S. (2001). Smoking cessation for individuals with mental illness or addictions. Psychiatric Services, 53, 1166–1170.

    Article  Google Scholar 

  • el-Guebaly, N., & Hodgins, D. (1992). Schizophrenia and substance abuse: Prevalence issues. Canadian Journal of Psychiatry, 37, 704–710.

    CAS  Google Scholar 

  • Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C., & Goff, D. C. (2001). A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation schizophrenia. Nicotine & Tobacco Research, 3, 397–403.

    Article  CAS  Google Scholar 

  • Evins, A. E., Rigotti, N. A., Freudenreich, O., Henderson, D. C., Olm-Shipman, C. M., & Goff, D. C. (2004). Two-year follow-up of a smoking cessation trial in patients with schizophrenia: Increased rates of smoking cessation and reduction. Journal of Clinical Psychiatry, 65, 307–311.

    Article  PubMed  Google Scholar 

  • George, T., Vessicchio, J. C., Termine, A., Bregartner, T. A., Feingold, A., Rounsaville, B. et al. (2002). A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry, 52, 53–61.

    Article  CAS  PubMed  Google Scholar 

  • George, T., Ziedonis, D., Feingold, A., Pepper, W., Satterburg, C., Winkel, J., & Kosten, T. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 1835–1842.

    Article  CAS  PubMed  Google Scholar 

  • Heatherton, T. F., Kozlowski, L., Frecker, R. C., & Fragerstrom, K. (1991). The Fagerstrom test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction, 86, 1119–1127.

    Article  CAS  PubMed  Google Scholar 

  • Himelhoch, S., & Daumit, G. (2003). To whom do psychiatrists offer smoking-cessation counseling? Psychiatry, 160, 2228–2230.

    Google Scholar 

  • Larsen, D., Attkinsson, C., Hargreaves, W., & Nguyen, T. (1979). Assessment of client/patient satisfaction: Development of a general scale. Evaluation and Program Planning, 2, 197–207.

    Article  CAS  PubMed  Google Scholar 

  • Lasser, K., Boyd, W., Woolhandler, S., Himmelstein, D., McCormick, D., & Bor, D. (2000). Smoking and mental illness: a population-based prevalence study. JAMA, 284, 2606–2610.

    Article  CAS  PubMed  Google Scholar 

  • Leonard, S., Breese, C., Adams, C., Benhammou, K., Gault, J., Stevens, K., Lee, M., Adler, L., Olincy, A., Ross, R., & Freedman, R. (2000). Smoking and schizophrenia: Abnormal nicotinic receptor expression. European Journal of Pharmacology, 393, 237–242.

    Article  CAS  PubMed  Google Scholar 

  • MacKay, B. (2004). Butting out in Canada: Five down, eight to go. Canadian Medical Association Journal, 171, 558.

    Article  PubMed  Google Scholar 

  • McChargue, D. E., Gulliver, S. B., & Hitsman, B. (2002). Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment. Addiction, 97, 785–793.

    Article  PubMed  Google Scholar 

  • Moll, S., Goldberg, J., Washington, A., & Pawlick, J. (1996). Smoking and people with mental health problems: A how-to guide for support people. Hamilton, ON: CSVR Foundation.

    Google Scholar 

  • Niaura, R., & Abrams, D. (2002). Smoking cessation: Progress, priorities, and prospectus. Journal of Consulting and Clinical Psychology, 70, 494–509.

    Article  PubMed  Google Scholar 

  • Steinberg, M. L., Ziedonis, D. M., Krejci, J. A., & Brandon, T. H. (2004). Motivational interviewing with personalized feedback: A brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. Journal of Consulting and Clinical Psychology, 72, 723–728.

    Article  PubMed  Google Scholar 

  • Thorndike, A. N., Stafford, R. S., & Rigotti, N. A. (2001). US physicians’ treatment of smoking in outpatients with psychiatric diagnoses. Nicotine and Tobacco Research, 3, 85–91.

    Article  CAS  PubMed  Google Scholar 

  • Ventura, J., Lukoff, D., Nuechteriein, K., Liberman, R. P., Green, M. F., & Shaner, A. (1993). Manual for the expanded brief psychiatric rating scale (BPRS). International Journal of Methods in Psychiatric Research, 22, 1–20.

    Google Scholar 

  • Williams, J. M., & Hughes, J. (2003). Pharmacotherapy treatments for tobacco dependence among smokers with mental illness or addiction. Psychiatric Annals, 33, 457–466.

    Google Scholar 

  • Williams, J. M., & Ziedonis, D. (2004). Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors, 29, 1067–1083.

    Article  PubMed  Google Scholar 

  • Williams, J. M., Ziedonis, D. M., & Foulds, J. (2004). A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia. Psychiatric Services, 55, 1064–1066.

    Article  PubMed  Google Scholar 

  • Ziedonis, D., Kosten, T., Glazer, W., & Frances, R. (1994). Nicotine dependence and schizophrenia. Hospital and Community Psychiatry, 45, 204–206.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This project was funded by an Alberta Alcohol and Drug Abuse Commission (Edmonton, AB, Canada) Tobacco Reduction Phase I grant. Each author has contributed significantly to the work and agrees on this submission.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shawn R. Currie.

Additional information

Portions of this paper were presented at: Currie, S., Karltyn, J., Lussier, D., Brown, D., and el-Guebaly, N. (2005, September). Smoking cessation program for persons with severe and persistent mental illness. Presentation at Global Perspectives on Chronic Disease Management: The Calgary Conference, Calgary, AB.

Currie, S., Lussier, D., Karltyn, J., el-Guebaly, N., Brown, D., and Goodale, L. (2004, November). A community-based smoking cessation program for persons with chronic mental illness. Presented at the 38th Annual Meeting of the Association for the Advancement of Behavior Therapy, New Orleans, LA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Currie, S.R., Karltyn, J., Lussier, D. et al. Outcome from a Community-based Smoking Cessation Program for Persons with Serious Mental Illness. Community Ment Health J 44, 187–194 (2008). https://doi.org/10.1007/s10597-007-9113-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10597-007-9113-8

Keywords

Navigation